Pilot study to evaluate glycemic control using GlucoTab in combination with continuous glucose monitoring in non-critically ill patients with type 2 diabetes at the general ward
- Conditions
- E11Type 2 diabetes mellitus
- Registration Number
- DRKS00030400
- Lead Sponsor
- Medizinische Universität Graz
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Informed consent obtained after being advised
of the nature of the study
-Male or female aged =18 years
-Type 2 diabetes (treated with diet, oral agents,
non-insulin injected anti-diabetic medicine,
insulin therapy or any combination of the four)
or newly diagnosed hyperglycemia which
requires s.c. insulin therapy
- Type 1 diabetes, gestational diabetes
- Any disease or condition which the
investigator or treating physician feels would
interfere with the trial or the safety of the
patient
- Hyperglycaemic episodes (ketoacidosis,
hyperosmolar state) if they require intravenous
insulin therapy
- Pregnancy
- Any mental condition rendering the patient
incapable of giving his consent
- Known or suspected allergy to adhesive
material/tape
- Skin pathologies that hinder application of a
CGM sensor
- Continuous parenteral nutrition
- Participation in another trial which can
influence outcome of the trial
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mean percentage of blood glucose <br>measurements in the target range 70 to 140 <br>mg/dl, as calculated by all premeal and bedtime<br>blood glucose values measured = 24 hours <br>after start of therapy
- Secondary Outcome Measures
Name Time Method